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Abstract
Background: The latent membrane protein (LMP) 2A of Epstein-Barr virus (EBV) is expressed during different
latency stages of EBV-infected B cells in which it triggers activation of cytoplasmic protein tyrosine kinases. Early
studies revealed that an immunoreceptor tyrosine-based activation motif (ITAM) in the cytoplasmic N-terminus of
LMP2A can trigger a transient increase of the cytosolic Ca
2+ concentration similar to that observed in antigen-
activated B cells when expressed as a chimeric transmembrane receptor. Even so, LMP2A was subsequently
ascribed an inhibitory rather than an activating function because its expression seemed to partially inhibit B cell
antigen receptor (BCR) signaling in EBV-transformed B cell lines. However, the analysis of LMP2A signaling has been
hampered by the lack of cellular model systems in which LMP2A can be studied without the influence of other
EBV-encoded factors.
Results: We have reanalyzed LMP2A signaling using B cells in which LMP2A is expressed in an inducible manner
in the absence of any other EBV signaling protein. This allowed us for the first time to monitor LMP2A signaling in
statu nascendi as it occurs during the EBV life cycle in vivo. We show that mere expression of LMP2A not only
stimulated protein tyrosine kinases but also induced phospholipase C-g2-mediated Ca
2+ oscillations followed by
activation of the extracellular signal-regulated kinase (Erk) mitogen-activated protein kinase pathway and induction
of the lytic EBV gene bzlf1. Furthermore, expression of the constitutively phosphorylated LMP2A ITAM modulated
rather than inhibited BCR-induced Ca
2+ mobilization.
Conclusion: Our data establish that LMP2A expression has a function beyond the putative inhibition of the BCR by
generating a ligand-independent cellular activation signal that may provide a molecular switch for different EBV life
cycle stages and most probably contributes to EBV-associated lymphoproliferative disorders.
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Background
A common feature of herpes viruses is their ability to
maintain latent infections during which no virus parti-
cles are produced. The oncogenic Epstein-Barr virus
(EBV) establishes such a latent infection in human B
cells [1]. At least four different types of EBV latency
have been described based on the expression patterns of
EBV genes including those encoding latent membrane
protein (LMP) 1 and 2A [2]. The lipid raft-resident
LMP2A contains 12 transmembrane domains and both,
the N- and C-terminus face the cytosol. An immunore-
ceptor tyrosine-based activation motif (ITAM) in the
LMP2A N-terminus is constitutively phosphorylated and
activates the protein tyrosine kinase (PTK) Syk [3]. This
enables LMP2A to support development and mainte-
nance of peripheral B cells in LMP2A transgenic mouse
models [4,5]. We have previously shown that for these
purposes LMP2A also employs the intracellular adapter
protein SLP65 (BLNK or BASH), which is a key effector
molecule of the B cell antigen receptor (BCR) [6].
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tion with the adaptor CIN85 nucleates assembly of the
Ca
2+ initiation complex comprising Bruton’st y r o s i n e
kinase (Btk) and phospholipase C (PLC)-g2 [7,8].
So far, the standard model system for biochemical
analysis of LMP2A signaling mechanisms was based on
EBV-transformed primary human B cells known as lym-
phoblastoid cell lines (LCL), which express, however,
several EBV gene products. Although early studies
demonstrated that the LMP2A ITAM in the context of
chimeric transmembrane proteins activates the Ca
2+
initiation complex, experiments using LCL suggested
that LMP2A acts as inhibitor of BCR-induced activation
signals and prevents mobilization of Ca
2+ ions from
intra- and extracellular sources [3,9,10]. This observa-
tion led to the hypothesis that LMP2A suppresses viral
replication which would be induced upon BCR activa-
tion of LMP2A-negative cells [11]. However, recent stu-
dies showed that constant activation of BCR-regulated
signaling pathways - as done by LMP2A - induces and
maintains BCR unresponsiveness resulting in B cell
anergy [12,13]. To circumvent this problem and to ana-
lyze LMP2A signaling in statu nascendi in non-anergic
cells in the absence of any other EBV gene product, we
now established a Cre/loxP-based system to inducibly
express LMP2A in B cells. We show that expression of
LMP2A not only activated PTKs but also the Ca
2+
initiation complex resulting in oscillatory Ca
2+ fluxes
similar to those observed after BCR stimulation. This
triggered activation of the mitogen-activated protein
kinase (MAPK) pathway as well as the expression of
EBV-encoded BZLF1, the master regulator of lytic EBV
replication. In addition, the constitutively phosphory-
lated LMP2A ITAM modulated BCR-induced Ca
2+
mobilization. Our results show that similar to the anti-
gen-activated BCR, induction of LMP2A expression can
trigger the lytic EBV replication cycle in an ITAM-
dependent manner. In contrast to the BCR, however,
the LMP2A activation signal does not require extracellu-
lar ligation.
Results
Online monitoring of LMP2A signaling events using the
cre/loxP recombination system
In order to investigate the signaling capacity of LMP2A
in statu nascendi during the first hours following its
expression in the absence of other EBV-encoded mole-
cules, we employed the Cre/loxP recombination system
to express LMP2A in an inducible manner in DT40 B
cells (for details see Methods and [14]). Briefly, treatment
of the cells with 4-hydroxytamoxifen (4-HT) triggered
Cre-mediated excision of a loxP site-flanked puromycin
resistance cassette from the LMP2A expression vector
(Figure 1A). This deletion brings the lmp2a cDNA under
transcriptional control of a promotor. Anti-FLAG immu-
noblotting showed that LMP2A expression was detect-
able 4 h upon 4-HT treatment and increased thereafter
(Figure 1B). A maximum was reached after an induction
period of 12 to 24 h. Beyond this time, the amount of
LMP2A declined continuously and was barely detectable
after 48 h (data not shown). The exact molecular
mechanisms that shut down LMP2A expression remain
to be elucidated but this phenomenon could possibly
explain why the generation of B cell transfectants that
stably produce significant amounts of LMP2A is hardly
feasible (data not shown). As shown in Figures 1C and
1D, induced expression of LMP2A activated PTKs and
triggered phosphorylation of LMP2A itself as well as cel-
lular substrates including the known downstream effec-
tors Syk and SLP65 [3,6]. The increasing intensities of
the anti-phosphotyrosine signals correlated with the
amount of LMP2A protein, indicating that different
LMP2A expression levels quantitatively and perhaps qua-
litatively regulate B cell signaling as suggested by Casola
et al. [5]. Notably, the overall tyrosine phosphorylation
pattern was very similar to that obtained upon BCR sti-
mulation of LMP2A-negative control cells. Thus, mere
expression of LMP2A is sufficient to constitutively acti-
vate B cell signaling cascades that are normally under
BCR control.
Early studies reported that when expressed in the
context of chimeric transmembrane proteins the
LMP2A ITAM required extracellular cross-linking to
activate PTKs and subsequent Ca
2+ mobilization
[15,16]. However, in those experiments the ITAM-con-
taining N-terminus of LMP2A having a type-II like
membrane topology was fused to type-I transmembrane
proteins whereby its physiological orientation was
inverted. To address a possible influence of the mem-
brane topology on the need for extracellular ligation we
analyzed the LMP2A N-terminus in the context of a
type-I or a type-II transmembrane protein, respectively
(see Figure 2A). Expression of a type-I CD8/LMP2A
fusionprotein indeed required extracellular cross-linking
to stimulate protein tyrosine phosphorylation (Figure
2B) and subsequent Ca
2+ mobilization (Figure 2C). In
contrast - but similar to wild-type LMP2A - expression
of the LMP2A N-terminus in the context of the type-II
transmembrane protein CD72 caused the constitutive
phosphorylation of intracellular signaling proteins which
was not enhanced upon extracellular ligation (Figure
2D). In line with our experiences gained with wild-type
LMP2A expression of the chimeric CD72/LMP2A
fusionprotein could only be achieved using our condi-
tional expression system (see Figure 1A and data not
shown) which strengthens the notion that expression of
a constitutively firing ITAM-containing receptor is not
tolerated by DT40 B cells.
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Figure 1 Induced expression of LMP2A in DT40 B cells causes PTK substrate phosphorylation. (A) LMP2A expression strategy. Treatment
of DT40 transfectants with 4-HT induces Cre-mediated excision of a loxP-flanked puromycin resistance cassette which otherwise prevents the
promotor (P) from activating transcription of a cDNA encoding triple-FLAG-tagged LMP2A (LMP2A3xF). (B), Following 4-HT treatment for the
indicated time points, expression of LMP2A3xF was monitored on the protein level by anti-FLAG immunoblotting of cellular lysates. (C) LMP2A
transfectants of DT40 B cells were treated with 4-HT for the indicated times (lanes 1-9), left untreated (lane 10) or stimulated for 3 min with anti-
IgM antibodies (lane 11). Upon lysis, tyrosine-phosphorylated proteins were purified using anti-phosphotyrosine antibodies (covalently coupledt o
NHS-Sepharose) and subjected to anti-phosphotyrosine (anti-pTyr) immunoblotting. Relative molecular masses of marker proteins are indicated
on the left in kDa. (D) The same cells as before were treated with 4-HT for the indicated times (lanes 1-8), left untreated (lane 9) or stimulated
for 3 min with anti-IgM antibodies (lane 10). After lysis in 1% NP40-containing lysis buffer, tyrosine-phosphorylated proteins were affinity purified
using a fusion protein consisting of GST and the tandem SH2 domains of Syk (GST-Syk[SH2]2). The GST-Syk[SH2]2 fusion protein specifically binds
to doubly phosphorylated ITAM motifs. Purified proteins were subjected to anti-phosphotyrosine immunoblotting. The positions of
phosphorylated LMP2A and the (non-phosphorylated) GST fusion protein are indicated on the right.
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Figure 2 Stimulation-dependent versus autonomous signaling of the LMP2A-ITAM. (A) Schematic representation of CD8- and CD72-based
transmembrane chimeras containing the cytoplasmic LMP2A N-terminus in type-I or type-II orientation, respectively. (B) DT40 transfectants,
which constitutively express CD8/LMP2A were left unstimulated (lane 1) or stimulated for 3 min with either anti-IgM or anti-CD8 antibodies
(lanes 2 and 3, respectively) and analyzed for PTK substrate phosphorylation by anti-phosphotyrosine immunoblotting as described in Figure 1C.
Identification of Syk and SLP65 phosphoproteins was performed in separate experiments (data not shown). Relative molecular masses of marker
proteins are indicated on the left in kDa. (C) Indo-1-loaded CD8/LMP2A transfectants were stimulated with anti-CD8 antibodies (arrow) and
mobilization of Ca
2+ ions was monitored by flow cytometry. (D) DT40 transfectants, which were left uninduced (lanes 1-2) or treated with 4-HT
for 6 h to induce expression of CD72/LMP2A (lanes 3-4) were analyzed for PTK substrate phosphorylation without stimulation (lanes 1 and 3) or
after stimulation (lanes 2 and 4) with antibodies against IgM or CD72, respectively, by anti-phosphotyrosine immunoblotting as described in
Figure 1C.
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Having established that mere expression of LMP2A or its
cytosolic N-terminus in its physiological orientation acti-
vates cytosolic PTKs, we next examined whether the sig-
nal chain proceeded to the PLC-g-controlled generation
of second messengers. Measurement of inositol-1,4,5-tri-
sphosphate (IP3) amounts in resting, LMP2A-expressing
or BCR-activated cells showed that LMP2A signaling
induced considerably increased steady-state amounts of
IP3 that reached about half of what was present at the
peak of the BCR response (Figure 3A). Single cell Ca
2+
flux analyses revealed that the elevated intracellular IP3
concentration gave rise to continuous cytosolic Ca
2+
spikes (Figure 3B) that mirrored those observed approxi-
mately 15 min after the initial peak in long-term mea-
surements of BCR-activated cells (Figure 3C). Again,
analysis of the CD72/LMP2A fusion protein paralleled
our findings with wild-type LMP2A (Figure 3D). In addi-
tion, the Ca
2+ waves triggered by LMP2A were directly
visualized by time lapse video imaging of Fluo-3-loaded
cells (see Additional files 1, 2 and 3: Figure S1). The
intensities of LMP2A-induced PTK activation and subse-
quent second messenger generation were sufficient to
activate downstream signaling cascades such as the Erk
MAP kinase pathway (Figure 4). Collectively, our data
demonstrate that the LMP2A ITAM in its physiological
membrane topology induces a ligation-independent acti-
vation signal during its initial expression that mimics that
of the antigen-activated BCR.
LMP2A signaling activates the EBV-encoded bzlf1 gene
To assess further downstream responses as well as the
functional significance of LMP2A-induced signals we
monitored transcriptional activation of EBV-encoded
bzlf1, which is the physiological trigger of the lytic repli-
cation cycle in EBV-infected host cells [17]. A reporter
gene assay was established in which the entire bzlf1 locus
including pZ promotor, open reading frame and two
potential polyadenylation sites was transfected into DT40
cells. With this experimental setup we recapitulated the
in vivo situation of EBV-infected cells in which BCR-
induced BZLF1 protein stimulates transcription of its
own promotor in a feed-forward loop [18]. Indeed, fol-
lowing BCR activation of the DT40 transfectants for 24
h, BZLF1 protein production was detected by anti-BZLF1
immunoblotting (Figure 5A, lane 1). BZLF1 was also
detectable following 16 h of 4-HT-mediated LMP2A
induction and a maximum was reached after approxi-
mately 36 h (lanes 3-8). Note that, prior to feed-forward
production of BZLF1, expression of LMP2A has to be
induced for several hours by 4-HT treatment (see Figure
1) explaining the different kinetics of BCR- versus
LMP2A-induced BZLF1 production. Likewise, the chi-
meric CD72/LMP2A protein, whose expression was
induced with a faster kinetics than wild-type LMP2A
(data not shown), triggered maximal BZLF1 production
after induction for 20-28 h (Figure 5B). Mutational analy-
sis of LMP2A signaling motifs showed that activation of
the pZ promotor required a functional ITAM as
exchange of its tyrosines to phenylalanine residues (Y74,
85 F) abrogated BZLF1 expression (Figure 5C, lanes 5-6).
Inactivation of a non-ITAM tyrosine residue supposed to
recruit the Src-family PTK Lyn (Y112F) only marginally
affected LMP2A-induced production of BZLF1 (compare
lanes 3-4 with 1-2). In contrast to the inducibly expressed
LMP2A variants, the CD8/LMP2A fusion protein again
required cross-linking with anti-CD8 antibodies to stimu-
late expression of BZLF1 in amounts similar to that
achieved by the ITAMs of either Iga or Igb (Figure 5D).
Taken together, ligand independent LMP2A activation
signals not only trigger cytosolic Ca
2+ waves and MAP
kinase activation but in addition to this translate into
nuclear responses at the crossroad of latency versus lytic
EBV replication.
LMP2A modulates BCR signaling
Early observations made in LCL suggested that LMP2A
may exert an inhibitory effect on BCR proximal signaling
events. To test this possibility we compared BCR-induced
Ca
2+ mobilization in B cells that did or did not express a
constitutively active LMP2A ITAM (Figure 6). Since wild-
type LMP2A was not detectable at the cell surface in our
cells (data not shown) as reported for transiently trans-
fected human B cells as well [19], we employed cells that
were induced to express the CD72/LMP2A chimera.
Expression of the chimera was detectable on the surface of
live cells by staining with anti-CD72 antibodies (Figure 6A
&6B). This allowed us to compare the BCR-induced Ca
2+
mobilization capacities of CD72/LMP2A-negative cells
(blue lines) and CD72/LMP2A-positive cells (red lines).
Notably, the presence of the constitutively active
LMP2A N-terminus drastically changed BCR-induced
Ca
2+ kinetics. While it delayed and dampened the peak
of the response it caused a sustained, long-lasting
increase in the cytosolic Ca
2+ concentration compared
with the relatively transient increase in wild-type cells. By
contrast, crosslinking of CD72/LMP2A had only a minor
effect on Ca
2+ mobilization (Figure 6, purple lines).
These data demonstrate that expression of the constitu-
tively tyrosine phosphorylated LMP2A N-terminus can
influence BCR proximal signaling mechanisms if both
molecules get active in the same cell at the same time.
Discussion
With this report we reinforce the concept that LMP2A
mimics BCR signal transduction [15,16]. The func-
tional similarities are, however, not restricted to mem-
brane-proximal signaling including PTK activation and
Engels et al. Cell Communication and Signaling 2012, 10:9
http://www.biosignaling.com/content/10/1/9
Page 5 of 11phosphorylation of SLP65 as previoulsy thought, but
extend to cytosolic Ca
2+ mobilization, activation of
downstream signaling pathways and even nuclear
responses such as activation of the EBV lytic gene
bzlf1. These events are reminiscent of the antigen-
induced BCR activation signal [7], which in fact
represents a trigger of lytic EBV replication [20]. It
thus appears that EBV possesses intrinsic and extrinsic
modes for reactivation from latency, namely expression
of and autonomous signaling by LMP2A as well as
extracellular B cell stimulation through surface recep-
tors such as the BCR.
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Figure 3 LMP2A induces oscillatory Ca
2+ waves caused by IP3 production. (A) DT40 cells that were left untreated (LMP2A -4-HT) or
induced to express LMP2A for 12 h (LMP2A +4-HT) were subjected to IP3 analysis using a competitive binding assay with
3H-labeled IP3.
Tamoxifen-treated parental cells (DT40 +4-HT) and cells that had been BCR-stimulated for three minutes (a-IgM) served as negative and positive
control, respectively. Error bars represent standard deviation of four independent measurements. (B) DT40 B cells that were rendered positive for
LMP2A expression by treatment with 4-HT for 14 h (black line) and LMP2A-negative DT40 cells treated with 4-HT for the same time (grey line)
were loaded with Fura-2-AM. Subsequently, single cell [Ca
2+] analysis giving the ratio of fluorescence intensities, F340/F380, was performed by
microscopic imaging for 5 min. One representative record of 50 is shown for each sample. (C) LMP2A-negative DT40 cells were stimulated with
anti-IgM antibodies (indicated by an arrow) and changes in intracellular Ca
2+ concentrations were monitored for 30 min at the single cell level.
(D) Fura-2-AM-loaded DT40 cells that were induced to express chimeric LMP72 (black line) or 4-HT treated LMP72-negative parental cells (grey
line) were monitored for Ca
2+ flux at the single cell level as described in B.
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compelled us to employ an inducible expression strategy
since permanent expression of the constitutively signaling
LMP2A-ITAM was not endured by DT40 cells. The
underlying molecular mechanisms that cause constitutive
signaling of the LMP2A-ITAM remain elusive but are
conserved in the type-II CD72/LMP2A fusion protein.
This finding can explain the apparent discrepancy of stu-
dies made with chimeric type-I transmembrane proteins
that required cross-linking with antibodies in order to sig-
nal and insights gained with full-length LMP2A in LCL.
The observed block of BCR signaling and bzlf1 tran-
scription in LCL might be due to expression of additional
EBV genes or a consequence of the cellular transformation
process or both [21]. In LCL the latency type-III program
is active, which normally operates only in proliferating
EBV-positive B cells during infectious mononucleosis and
post-transplantation lymphoproliferative disorders. This
“EBV growth program” is characterized by the transcrip-
tion of all EBV latency genes leading to the production of
not only LMP2A but also LMP1, several Epstein-Barr
nuclear antigens (EBNAs) as well as non-coding RNAs
[22]. All of these molecules, perhaps in conjunction with
the altered protein expression profile of transformed cells,
may contribute to the particular LCL signaling phenotype.
Furthermore, constant activation of BCR-regulated signal
transducers leads to inhibitory feedback mechanisms that
cause BCR unresponsiveness [13], a phenomenon that is
most likely caused by continuous LMP2A expression alike.
Nevertheless, our experiments show that the mere pre-
sence of the constitutively phosphorylated LMP2A N-ter-
minus can modulate BCR proximal signaling events in
non-anergic cells.
In the absence of a BCR, transgenic LMP2A expression
can replace BCR signaling required for the development
and survival of peripheral B cells [5,23,24]. As signaling for
B cell survival requires a functional Ca
2+ machinery, i.e.
SLP65 as well as enzymatically active Btk and PLC-g2
[25-27], LMP2A must be able to trigger these molecules
since otherwise it could not mediate development and
maintenance of B cells in transgenic mice. As LMP2A sig-
nals autonomously without the need for extracellular liga-
tion, it is most probably its amount produced in an
individual cell that determines whether a maintenance sig-
nal or an activation signal is generated. Thus, moderate
expression of LMP2A would drive B cell development and
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Figure 4 LMP2A expression activates the Erk MAP kinase cascade. DT40 cells were left untreated (lanes 1, 5 & 9) or induced to express
LMP2A (lanes 6-8) or CD72/LMP2A (lanes 10-12) for the indicated times in the absence or presence of 50 M PD98059 (PD, lanes 4, 8 & 12).
Parental cells served as control (MCM, lanes 1-4). Erk activation was monitored by immunoblot analysis of total cellular lysates with phospho-Erk-
specific antibodies (upper panel). The membrane was sequentially re-probed with antibodies to the FLAG-tag, CD72 and Erk to demonstrate
protein induction as well as equal protein loading.
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Figure 5 LMP2A-mediated signaling induces expression of BZLF1. DT40 transfectants stably transfected with a BZLF1 reporter construct (see
text for details) were induced with 4-HT to express either wild-type LMP2A (A) or chimeric CD72/LMP2A (B) for the indicated times (lanes 2-8).
As control, cells were cultured for 24 h in the presence of anti-IgM antibodies (lanes 1). Subsequently, cleared cellular lysates were subjected to
immunoblot analysis with antibodies to BZLF1 or actin (upper and lower panels, respectively). (C) DT40 transfectants were left untreated or
induced for 24 h to express either CD72/LMP2A (lanes 1- 2) or phenylalanine mutants Y112F (lanes 3-4) or Y74,85 F (lanes 5-6). BZLF1 protein
expression was analyzed as described in A. (D) DT40 transfectants constitutively expressing chimeric CD8/LMP2A, CD8/Iga or CD8/Igb,
respectively, were either left untreated (0) or were stimulated with 10 μg/ml monoclonal anti-CD8 antibody for 24 h. Subsequently expression of
BZLF1 and actin was analyzed as in A. Relative molecular mass of a marker protein is indicated on the left of the blots in kDa. Values below anti-
BZLF1 blots indicate integrated optical densities of BZLF1 bands normalized to the corresponding actin bands.
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unligated BCR. Elevated LMP2A expression by contrast
mimics the activation signal of the antigen-stimulated
BCR and leads to Ca
2+ mobilization and production of
BZLF1. Indeed, when LMP2A was transiently transfected
into non-anergic EBV-positive B cells, it induced entry
into the EBV lytic cycle, which is associated with produc-
tion of BZLF1 and Virus Capsid Antigen [28]. This may
induce lytic EBV replication and contribute to the onset of
severe lymphoproliferative disorders that are often asso-
ciated with EBV infection especially in immunocompro-
mised hosts [29,30].
Conclusion
In conclusion, online monitoring of LMP2A expression
and signaling in non-anergic B cells uncovered an acti-
vation mechanism for virus-intrinsic regulation of lytic
genes involving second messenger-controlled cellular
signaling pathways. The autonomously activated signal
chains can activate bzlf1 transcription and thereby ren-
der the lytic EBV replication cycle independent of
extrinisic regulators. Moreover, the activation signal
emanating from LMP2A is likely to contribute to EBV-
associated lymphoproliferative disorders like Hodgkin
lymphoma and post transplantation lymphomas.
Methods
Plasmids and cDNAs
The lmp2a cDNA was amplified from an LCL (EBV
strain B95-8). A triple FLAG-tag coding sequence was
introduced by PCR into the coding sequence of the first
extracellular loop resulting in LMP2A3xF which was
ligated into pcDNA3 (Invitrogen) or pABESII. A puromy-
cin resistance cassette flanked by two loxP sites was posi-
tioned between promotor and lmp2a3xF cDNA.
Chimeric LMP2A/CD72 was generated by ligating the
coding region of the LMP2A N-terminus (codons 1-121)
to the coding sequence of transmembrane and extracellu-
lar parts of mouse CD72 (kindly provided by T. Tsubata,
Tokyo, Japan). Chimeric CD8 constructs were generated
alike (CD8 cDNA was kindly provided by B. Schraven,
Magdeburg, Germany). The bzlf1 locus comprising
Figure 6 The LMP2A N-terminus modulates BCR signaling. DT40 transfectants were induced with 4-HT to express chimeric CD72/LMP2A,
loaded with Indo-1 and stained with FITC-labeled anti-CD72 in order to gate on CD72 negative and CD72 positive cells (upper panels).
Subsequently, BCR-induced Ca
2+ responses were monitored by flow cytometry (lower panels) upon stimulation of the cells with anti-IgM
antibodies (blue and red curves) or with anti-mouse IgG F(ab)2 fragments to super-crosslink the anti-CD72 antibody (purple and yellow curves).
Blue and yellow lines represent CD72/LMP2A-negative cells, red and purple lines CD72/LMP2A-positive cells. (A) and (B) represent two indepent
cell clones.
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two potential polyadenylation sites was PCR-amplified
from an LCL (EBV strain B95-8) and ligated into
pBS82HisD [31] carrying a histidinol resistance gene.
Sequences of oligonucleotides are available upon request.
Cells and antibodies
MerCreMer-expressing DT40 cells (kindly provided by
T. Brummer and M. Reth, Freiburg, Germany) were
maintained in RPMI1640 + GlutaMAX (Invitrogen) sup-
plemented with 10% FCS and 1% chicken serum. Trans-
location of MerCreMer to the nucleus was induced by
addition of 200 nM 4-hydroxytamoxifen (4-HT, Sigma,
Munich, Germany). For stable transfections, 10
7 cells sus-
pended in ice-cold PBS containing 30 μg of linearized
expression vectors were electroporated using a Gene-Pul-
ser (BioRad, Munich, Germany) (260 V, 960 μFi na4
mm cuvette) and selected in the presence of 2 mg/ml
G418, 1 mg/ml histidinol or 0.5 μg/ml puromycin,
respectively. Monoclonal antibodies against BZLF1
(clone BZ.1) and human CD8 (MEM-31) were kind gifts
of M. Rowe, Birmingham, UK or V. Horejsi, Prague,
Czech Republic, respectively. Anti-FLAG (M2) was pur-
chased from Sigma (Munich, Germany), anti-CD72
(K10.6) from BD Biosciences (Heidelberg, Germany),
anti-phosphotyrosine (4G10) from Upstate (Biomol,
Hamburg, Germany) and anti-phospho-Erk (E10) from
CST (NEB, Frankfurt, Germany). Anti-chicken IgM anti-
body (M4) was purified from hybridoma supernatant.
Prior to BCR stimulation, DT40 cells were starved for
30 min in RPMI without sera at 37°C and subsequently
incubated with 3 μg/ml M4.
Protein analysis
Cell lysis in 1% NP-40 buffer and immunopurification of
cellular proteins have been described previously [6]. For
specific immunodetection of FLAG-tagged LMP2A 10
6
cells were suspended in 30 μl Laemmli buffer, incubated
for 2 min at 75°C and homogenized by repeatedly passing
through a 26 gauge needle. Immunoblots were developed
with ECL (GE Healthcare, Freiburg, Germany) using a
digital image acquisition system (Intas Chemilux Entry,
Intas, Göttingen, Germany). Densitometric analysis of
individual protein bands on immuno blots was carried
out with GelPro Analyzer software (Media Cybernetics,
Silver Spring, MD, USA).
Ratiometric Ca
2+ measurements and IP3 analysis
10
6 DT40 cells were loaded with either 1 μMI n d o - 1 -
AM or 0.25 μM Fura-2/AM (Molecular Probes) in
RPMI containing 5% FCS and 0.015% pluronic acid at
30°C for 25 min. Subsequently, the cell suspension was
diluted 2-fold with RPMI + 10% FCS and incubated for
10 min at 37°C. Cells were washed and resuspended in
Krebs Ringer solution composed of 10 mM HEPES (pH
7.0), 140 mM NaCl, 4 mM KCl, 1 mM MgCl2,1m M
CaCl2 and 10 mM glucose. After monitoring basal [Ca
2
+] levels for 1 min, cells were stimulated with 3 μg/ml
M4. The ratio of Ca
2+ bound vs. Ca
2+ unbound Indo-1
fluorescence (405 nm/530 nm) was monitored on an
LSR II cytometer (Becton Dickinson). Single cell ratio-
metric [Ca
2+] measurements with Fura-2 were per-
formed using an upright microscope (Axioskop 2, Zeiss,
Göttingen, Germany) with a 40 × /0.9 water immersion
objective. Alternating excitation wavelengths at 340 and
380 nm were provided by a custom-built monochroma-
tor consisting of a Xenon lamp, a galvanometer-driven
mirror, appropriate filters, and a shutter. Image pairs
F340/F380 (alternating excitation at 340 and 380 nm;
emission > 505 nm) of individual cells were taken at 0.5
Hz or 1 Hz using a frame-transfer, back-illuminated
CCD camera (16 bits/pixel, Micromax; Visitron,
Munich, Germany) and a custom-built monochromator.
Images were acquired at 100 ms exposure time per
image. Galvanometer, shutter as well as the CCD’s
acquisition and recording software (Winview, Visitron)
were synchronized by a custom-built microcontroller
programmed in C language. Image analysis was per-
formed using custom programs written in MatLab (The
MathWorks, Natick, MA). IP3 amounts from 5 × 10
6
cells were determined using the D-myo-Inositol 1,4,5-tri-
sphosphate [
3H] Biotrak Assay System (GE Healthcare,
Freiburg, Germany) according to the manufacturers
instructions.
Additional material
Additional file 1: Time Lapse Video Imaging of Ca
2+ Flux in LMP2A-
expressing DT40 cells.
Additional file 2: Figure S1A.
Additional file 3: Figure S1B.
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